8-Chloroadenosine is under investigation in clinical trial NCT02509546 (8-chloroadenosine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.